Research progress of pan-immune inflammation value in prognosis and effect of tumors
- VernacularTitle:泛免疫炎症指数在肿瘤预后疗效的研究进展
- Author:
Tianyi LI
1
;
Yue REN
;
Zhenya SONG
;
Meinan JIANG
;
Mengyang LI
;
Yong CHEN
;
Xudong YIN
Author Information
- Keywords: tumors; pan-immune inflammation value; prediction; prognosis; efficacy; biomarkers
- From: Journal of Clinical Medicine in Practice 2024;28(5):139-143
- CountryChina
- Language:Chinese
- Abstract: Pan-immune inflammation value(PIV)is a comprehensive immune inflammatory bio-marker based on complete blood cell counts,which has been proven to predict treatment response and survival outcomes for different types of tumors.However,the predictive value of the PIV varies in dif-ferent strategies for tumor treatment.This paper aims to systematically review the latest progress of PIV in predicting survival outcomes and tumor prognosis for immunotherapy,radiotherapy,targeted therapy,endocrine therapy,surgical treatment and neoadjuvant therapy,and analyze its existing challenges and issues,as well as look forward to its future development direction and application prospects.
